This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (22)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Dermatology  • Melanoma  • Surgical Oncology  • Prognosis/ Outcomes  • Alert me on articles by topic  Social Bookmarking   What's this?

Cecelia E. Schmalbach, MD; Brian Nussenbaum, MD; Riley S. Rees, MD; Jennifer Schwartz, MD; Timothy M. Johnson, MD; Carol R. Bradford, MD

Arch Otolaryngol Head Neck Surg. 2003;129:61-65.

Objectives  To determine (1) the reliability of sentinel lymph node mapping with biopsy (SLNB) in head and neck cutaneous melanoma to accurately stage nodal basins and (2) the safety of SLNB in both the neck and parotid regions.

Design  Retrospective cohort study with a median follow-up of 25 months. All patients had a minimum follow-up of 1 year.

Setting  Academic medical center.

Patients  Eighty evaluable patients diagnosed as having head and neck cutaneous melanoma and staged using SLNB.

Interventions  Sentinel lymph nodes were identified using preoperative lymphoscintigraphy and a combination of intraoperative gamma probe and isosulfan blue dye. Patients with a SLN positive for melanoma underwent therapeutic lymphadenectomy followed by an evaluation for adjuvant therapies. Patients with a negative SLNB result were followed up clinically.

Main Outcome Measures  Percentage of positive SLNs, regional recurrence in the setting of a negative SLNB result (false-negative rate), and procedure complications.

Results  The mean Breslow depth was 2.35 mm. A SLN was identified in 77 (96.3%) of cases, with an average of 2.18 nodes per patient. Of the sentinel nodes identified, 74% were from the neck region. The remaining 26% were from the parotid basin. No facial nerve complications occurred. Of the patients, 14 (18%) were SLN positive for metastatic melanoma. The regional failure rate in the setting of a negative SLNB result was 4.5%.

Conclusions  Sentinel lymph node mapping with biopsy is a reliable technique to diagnose regional spread from head and neck cutaneous melanoma. This procedure can be performed in both neck and parotid nodal basins with safety and accuracy similar to non–head and neck sites.

From the Department of Otolaryngology–Head and Neck Surgery (Drs Schmalbach, Nussenbaum, Johnson, and Bradford), Department of Surgery, Section of Plastic Surgery (Dr Rees and Johnson), and Department of Dermatology (Drs Schwartz and Johnson), University of Michigan, Ann Arbor.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Sentinel Lymph Node Biopsy for Sebaceous Cell Carcinoma and Melanoma of the Ocular Adnexa
Ho et al.
Arch Otolaryngol Head Neck Surg 2007;133:820-826.
ABSTRACT | FULL TEXT  

Incidence and Prognosis of Cutaneous Melanoma Involving the Head and Neck
Bradford and Levine
JAMA 2007;297:2628-2629.
FULL TEXT  

Reliability of Sentinel Lymph Node Biopsy for Regional Staging of Head and Neck Merkel Cell Carcinoma
Schmalbach et al.
Arch Otolaryngol Head Neck Surg 2005;131:610-614.
ABSTRACT | FULL TEXT  

Staging Workup, Sentinel Node Biopsy, and Follow-up Tests for Melanoma: Update of Current Concepts
Johnson et al.
Arch Dermatol 2004;140:107-113.
ABSTRACT | FULL TEXT